Where Molecular Imaging Is Taking Us
P Kinahan1*, R Jeraj2*, W Weber3*, (1) University of Washington, Seattle, WA, (2) University of Wisconsin, Madison, WI, (3) , University Hospital Freiburg. GermanyTU-C-217BCD-1 Tuesday 10:30:00 AM - 12:30:00 PM Room: 217BCD
Molecular imaging techniques can detect abnormalities very early in the progression of a disease, often before problems can be observed with other diagnostic tests or even before symptoms occur. This in turn can improve the probability of a successful outcome. Additionally, Molecular imaging can determine if there has been a response to therapy early in the treatment phase, allowing for the selection an effective therapy and/or the development of improved therapies in clinical trials. There are many molecular imaging procedures that are currently available and essential in many medical specialties. Increased capabilities to image the human body are deepening our understanding of disease and allowing researchers to explore new ways to manage and treat illnesses. This symposium will describe the current state of the art in molecular imaging of cancer, where it is used for diagnosis, treatment planning, and assessing response to therapy. Challenges to implementation will be discussed and illustrative examples will be provided.